News & Press

BAS Research featured on Dr Oz
BAS Research featured on Dr Oz

On an episode of “The Dr. Oz Show,” Montel Williams takes viewers inside BAS Research.

BAS Research’s CEO, Dr. Bao Le Interviewed by The Sacramento Bee
BAS Research’s CEO, Dr. Bao Le Interviewed by The Sacramento Bee

Dr. Bao Le got into the medical marijuana business about eight years ago after his son was diagnosed with autism...

BAS Research’s CSO, Robert Sindelar Interviewed by Herb
BAS Research’s CSO, Robert Sindelar Interviewed by Herb

We spoke with some industry experts from BAS Research and Cloudponics to see there’s any truth to this age-old stoner binary: Indica or Sativa?

BAS Research’s Advisor interviewed by Entrepreneur.
BAS Research’s Advisor interviewed by Entrepreneur.

While others may see tremendous challenges and stigma in the weed business, many women see opportunity. “Women are used to having to go above and beyond to prove...

OUR REASON

These are the stories that inspire us to focus on our mission – to heal the world by
making safe cannabis and hemp-based products.

Meet the First Baby Ever Treated with Cannabis CBD Oil at The Hospital
Meet the First Baby Ever Treated with Cannabis CBD Oil at The Hospital

For the first time ever, cannabis oil will be used in a hospital... To save a 2-month-old baby girl

Cannabidiol significantly reduces seizures in patients with severe form of epilepsy
Cannabidiol significantly reduces seizures in patients with severe form of epilepsy

A new large-scale, randomized, controlled trial was able to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox-Gastaut syndrome.

Cannabidiol helps reduce seizures in people with severe form of epilepsy, study suggests
Cannabidiol helps reduce seizures in people with severe form of epilepsy, study suggests

A key cannabis compound helped to reduce the number of drop seizures in patients with a severe form of epilepsy, newly published results of a clinical trial suggest.

A drug derived from cannabis may be the first of its kind to treat a rare form of epilepsy
A drug derived from cannabis may be the first of its kind to treat a rare form of epilepsy

An experimental drug derived from cannabis to treat epilepsy is on the brink of becoming the first of its kind to win US government approval.

OUR COLLABORATION

Meet some of the partners that we collaborate with every day.

BAS Research @ MJBizCon – 2017 Recap
BAS Research @ MJBizCon – 2017 Recap

A recap of everything that happened at the BAS Booth on the 2017 edition of MJBizCon.

BAS Research @ MJBizCon – Eel River Organics Interview
BAS Research @ MJBizCon – Eel River Organics Interview

Dr. Bao Le interviews Brieanne Mirjah - Director of Sales and Marketing - Eel River Organics

BAS Research @ MJBizCon – Seven Points Interview
BAS Research @ MJBizCon – Seven Points Interview

Dr. Bao Le interviews Glenn Kassel - Seven Points Group

PRESS RELEASES

New partnerships and clients announcements.

BAS Research Executes Agreement for Exclusive Manufacturing Rights to Dr. Raw Organics
BAS Research Executes Agreement for Exclusive Manufacturing Rights to Dr. Raw Organics

Partnership will encompass full line of premium, 100% organic cannabis edibles, concentrates and topical products in California

BAS Research Announces Exclusive License of James Henry SF
BAS Research Announces Exclusive License of James Henry SF

The licensing partnership between BAS Research and James Henry SF underscores both company's commitments to responsibly utilize the medicinal and therapeutic benefits of CBD and THC

BAS Research Signs Agreement With Dr. Kerklaan Therapeutics for California Manufacturing Rights
BAS Research Signs Agreement With Dr. Kerklaan Therapeutics for California Manufacturing Rights

The partnership between BAS Research and Dr. Kerklaan Therapeutics will create high-quality medicinal cannabis products for the California marketplace

Resources & Press Inquiry

Logos & Lab Photos

We would love to answer any question you may have!

Contact us at: press@basresearch.com

Leave a Reply